Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship Between Gut Bacteria and Levodopa Metabolism

20 Oct 2022

Abstract excerpt

Parkinson's disease (PD) is one of the most common neurodegenerative diseases, characterized by the reduction of dopamine neurons in the substantia nigra. Levodopa, as a dopamine supplement, is the gold-standard therapeutic drug for PD. The metabolism of levodopa in the periphery not only decreases its bioavailability but also affects its efficacy. Thus, it is necessary to investigate how levodopa is metabolized....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gut microbiota and health
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36278467
DOI: 10.2174/1570159x21666221019115716

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship Between Gut Bacteria and Levodopa MetabolismPMID 36278467Read ↗

A review of studies on gut microbiota and levodopa metabolismSemantic proximity Read ↗

Association of Enterococcus faecalis and tyrosine decarboxylase gene levels with levodopa pharmacokinetics in Parkinson’s diseaseSemantic proximity Read ↗

Implications of Parkinson’s disease-associated alterations in the oral and gut microbiome on vitamin B12 biosynthesis and levodopa bioavailabilitySemantic proximity Read ↗

Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa‐carbidopa intrajejunal gelSemantic proximity Read ↗

High Throughput Assessment of Gut Bacterial Tyrosine Decarboxylase Activity for Predicting Peripheral Levodopa Loss in Parkinson's DiseaseSemantic proximity Read ↗

Exploring the role of gut microbiota in advancing personalized medicineSemantic proximity Read ↗

Identification of volatile metabolites produced from gut microbial levodopa metabolism using an untargeted metabolomics approachSemantic proximity Read ↗

Vitamin B6 produced by gut microbiome regulates host behavioral phenotypes through dopaminergic metabolism.Semantic proximity Read ↗

Effect of Parkinson’s disease and related medications on the composition of the fecal bacterial microbiotaSemantic proximity Read ↗

Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes.Semantic proximity Read ↗

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patientsSemantic proximity Read ↗

High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.